Patent · US Active

Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

US9588129B2 · kind B2 · utility

0Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateMar 7, 2017
Priority date
Expiry dateMar 15, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/285
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of detecting a disease associated with abnormal protein aggregation in a subject is provided, the method comprising (a) contacting leukocytes from the subject with a probe that binds to pathogenic protein aggregates, and (b) detecting the probe bound to the pathogenic protein aggregates, wherein the presence of pathogenic protein aggregates in the leukocytes is indicative that the subject has a disease associated with abnormal protein aggregation. In one embodiment, the disease is Alzheimer's disease or mild cognitive impairment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.